Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schuetz, Philip
TOASST, NCT03153527: Taper Or Abrupt Steroid Stop: trial	Recruiting	4	573	Europe	Prednisone, Placebo Arm	University Hospital, Basel, Switzerland, Kantonsspital Baselland Bruderholz, Swiss National Science Foundation, HEMMI Stiftung Switzerland	Inflammatory Disorder, Autoimmune	12/24	12/24
Meyer, Gesine
TOASST, NCT03153527: Taper Or Abrupt Steroid Stop: trial	Recruiting	4	573	Europe	Prednisone, Placebo Arm	University Hospital, Basel, Switzerland, Kantonsspital Baselland Bruderholz, Swiss National Science Foundation, HEMMI Stiftung Switzerland	Inflammatory Disorder, Autoimmune	12/24	12/24
TRANSIT, NCT04028219: Transgender In Transition	Recruiting	N/A	750	Europe	Online surveys	Universitätsklinikum Hamburg-Eppendorf	Gender Incongruence	05/24	05/34